Healthcare
Live Price
Offline$77.60
-2.62% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Brookdale Senior Living Inc. 7. (BKDT) is a Healthcare stock with a market cap of $1.23B. The stock last traded around $77.60. Baseline metrics include revenue growth of +2.2%, EPS growth of -25.8%, a dividend yield of 0.0%. What stands out right now is revenue +2.2%, EPS -25.8%, free cash flow +721.6% with operating margin 0.5% and ROIC 0.3%. Valuation is more restrained than many high-expectation growth names at price/sales 1.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BKDT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BKDT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BKDT Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BKDT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.7B
+0.0% YoY
FY Net Income
-$99.3M
+58.4% YoY
Free Cash Flow
-$271.3M
-40.1% YoY
Revenue Growth
+2.2%
EPS Growth
-25.8%
Gross Margin
20.6%
Net Margin
-8.4%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.2B | 3.1B | 3.0B | 2.7B | 2.7B |
| Gross Profit | 0 | 799M | 738M | 514M | 489M |
| Operating Income | 13M | 47M | 18M | -43M | -217M |
| EBITDA | 91M | 413M | 370M | 206M | 193M |
| Net Income | -263M | -202M | -189M | -238M | -99M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 279M | 309M | 278M | 399M | 347M |
| Total Assets | 6.0B | 6.3B | 5.6B | 5.9B | 6.4B |
| Total Liabilities | 6.0B | 6.1B | 5.2B | 5.4B | 5.7B |
| Shareholder Equity | -45M | 212M | 404M | 583M | 697M |
| Total Debt | 1.3B | 5.7B | 4.7B | 4.9B | 5.2B |
| Net Debt | 1.0B | 5.3B | 4.4B | 4.5B | 4.9B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
95M
-2984.3% YoY
Capital Expenditures
177M
+10.3% YoY
Free Cash Flow
271M
-40.1% YoY
Key ratios
Gross Margin
20.6%
Operating Margin
0.5%
Net Margin
-8.4%
ROE
-523.8%
Debt / Equity
-148.91x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.